Q2 2026 13F · SEC CIK 1422848

Capital Research Global Investors

Asset managerFiled 2026-08-12 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value: $716.8B
Reported positions: 424
Top holdings a year, 3 yrs: +25.5%
Average holding period: 7.8 yrs

Capital Research Global Investors is an asset manager that reported 424 positions worth $716.8B in its Q2 2026 13F, filed 2026-08-12. Its largest holdings were Broadcom Inc (AVGO, 6.0%), Nvidia Corporation Com (NVDA, 5.7%), Microsoft Corp (MSFT, 4.9%). A portfolio copying its top holdings returned 25.5% a year over the last 3 years, against 20.4% for the S&P 500.

Capital Research Global Investors holdings largest 50 of 424 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Capital Research Global Investors 13F holdings
Stock	% of 13F value	Q1 2026	Shares	Share change	Reported value
AVGOBroadcom Inc	6.0%	5.6%	113,126,312	-2.5%	$42.7B
NVDANvidia Corporation Com	5.7%	5.2%	202,740,420	+5.0%	$40.6B
MSFTMicrosoft Corp	4.9%	5.5%	94,750,369	-1.4%	$35.3B
AMZNAmazon Com Inc Com	4.0%	3.8%	120,603,873	+1.8%	$28.7B
LLYLilly Eli & Co	3.5%	3.5%	20,873,140	-15.3%	$25.0B
GOOGLAlphabet Inc	3.1%	2.6%	62,527,250	+8.7%	$22.3B
METAMeta Platforms Inc Class A	3.1%	2.7%	39,619,778	+28.2%	$22.3B
AAPLApple Inc	2.4%	2.5%	59,393,712	-7.2%	$17.2B
AMATApplied Matls Inc	2.2%	1.6%	22,159,097	-24.8%	$16.0B
PMPhilip Morris Intl Inc Com	2.1%	2.0%	84,253,663	+5.6%	$15.2B
GOOGAlphabet Inc	2.1%	1.8%	42,891,466	+6.4%	$15.2B
GEGe Aerospace	1.6%	1.5%	30,942,708	-10.9%	$11.6B
SBUXStarbucks Corp Com	1.6%	1.4%	109,649,535	+7.1%	$11.2B
RCLRoyal Caribbean Group	1.5%	1.2%	34,256,274	+21.2%	$10.9B
INTCIntel Corp	1.4%	0.5%	73,749,883	-4.6%	$10.3B
RTXRtx Corporation Com	1.4%	1.6%	52,346,255	+0.0%	$9.9B
VRTXVertex Pharmaceuticals Inc	1.4%	1.5%	19,490,637	-7.7%	$9.7B
UBERUber Technologies Inc	1.3%	1.3%	130,662,156	+12.3%	$9.4B
JPMJpmorgan Chase & Co	1.3%	1.3%	27,746,323	+1.2%	$9.1B
LINLinde PLC	1.3%	1.2%	17,430,716	+8.6%	$9.0B
CSCOCisco Sys Inc	1.1%	0.8%	67,174,294	+5.0%	$7.9B
CARRCarrier Global Corporation	1.1%	1.0%	106,065,347	-8.9%	$7.8B
ABBVAbbvie Inc	1.1%	1.1%	30,101,551	-3.7%	$7.6B
WFCWells Fargo Co New	0.9%	0.9%	76,395,745	+4.8%	$6.3B
GLWCorning Inc.	0.9%	—	24,698,700	—	$6.3B
MAMastercard Inc.	0.8%	1.1%	11,626,317	-16.3%	$6.0B
HDHome Depot Inc Com	0.8%	0.8%	16,802,396	+12.1%	$5.9B
ORCLOracle Corp	0.8%	0.7%	39,746,237	+23.7%	$5.8B
PGRProgressive Corp.	0.8%	0.7%	26,549,107	+17.6%	$5.8B
MELIMercadolibre Inc	0.7%	0.7%	3,138,040	+15.5%	$5.3B
APHAmphenol Corp	0.7%	0.5%	29,487,845	+10.7%	$5.2B
DDominion Energy Inc	0.7%	0.5%	73,855,890	+50.8%	$5.0B
TSMTaiwan Semiconductor Manufac	0.7%	0.5%	10,474,198	+4.9%	$5.0B
NFLXNetflix Inc Total	0.7%	1.0%	68,701,246	+1.0%	$4.9B
UNPUnion Pac Corp	0.6%	0.6%	17,112,417	+1.2%	$4.7B
CNQCanadian Nat Res Ltd Med Term Com	0.6%	1.2%	116,067,730	-29.4%	$4.6B
XOMExxon Mobil Corp	0.6%	0.9%	33,342,063	-1.1%	$4.6B
MUMicron Technology Inc	0.6%	—	3,827,473	—	$4.4B
UNHUnitedhealth Group Inc Com	0.6%	0.7%	10,534,177	-38.4%	$4.4B
BLKBlackrock Inc	0.6%	0.7%	4,458,212	-3.3%	$4.3B
MOAltria Group Inc	0.6%	—	58,653,624	—	$4.2B
STXSeagate Technology Hldngs Pl	0.6%	—	4,326,781	—	$4.2B
CVNACarvana Co	0.6%	0.5%	63,423,386	+484.5%	$4.2B
TDGTransdigm Group Inc	0.6%	0.6%	3,119,490	-0.8%	$4.2B
MDLZMondelez International Inc.	0.6%	0.6%	69,663,227	+2.0%	$4.0B
MSMorgan Stanley Com New	0.5%	0.5%	18,070,606	-10.9%	$3.8B
TSLATesla Inc Com	0.5%	0.5%	8,499,204	-1.5%	$3.6B
ABTAbbott Laboratories	0.5%	0.8%	36,908,990	-25.8%	$3.3B
CNPCenterpoint Energy Inc	0.4%	0.5%	71,382,073	-1.2%	$3.1B
APDAir Products and Chemicals Inc	0.4%	—	10,602,157	—	$3.1B

What Capital Research Global Investors bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year: +16.3% /yr; S&P 500 +20.1%
3 years: +25.5% /yr; S&P 500 +20.4%
5 years: +15.1% /yr; S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value and rebuilt each quarter on the day the filing became public. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter	13F value	Positions
Q2 2026	$716.8B	424
Q1 2026	$644.6B	458
Q4 2025	$541.7B	433
Q3 2025	$533.0B	433
Q2 2025	$499.4B	428
Q1 2025	$459.9B	455
Q4 2024	$486.3B	437
Q3 2024	$481.1B	415
Q2 2024	$455.7B	414
Q1 2024	$442.0B	410
Q4 2023	$406.5B	408
Q3 2023	$363.2B	410

Questions about Capital Research Global Investors's portfolio

What stocks does Capital Research Global Investors own?

Capital Research Global Investors's latest 13F, for Q2 2026 and filed Aug 12, 2026, lists 424 positions worth $716.8B. The largest are Broadcom Inc (AVGO) at 6.0%, Nvidia Corporation Com (NVDA) at 5.7%, Microsoft Corp (MSFT) at 4.9%, Amazon Com Inc Com (AMZN) at 4.0% and Lilly Eli & Co (LLY) at 3.5%.

What did Capital Research Global Investors buy last quarter?

In Q2 2026, Capital Research Global Investors added Carvana Co (CVNA) (+484.5% shares), Dominion Energy Inc (D) (+50.8% shares) and Meta Platforms Inc Class A (META) (+28.2% shares), compared with its Q1 2026 filing.

What did Capital Research Global Investors sell last quarter?

In Q2 2026, Capital Research Global Investors cut from its top 50 Gilead Sciences (GILD), cut from its top 50 Eog Res Inc (EOG), cut from its top 50 Medtronic PLC (MDT), cut from its top 50 Nextera Energy Inc Com (NEE), cut from its top 50 Alnylam Pharmaceuticals Inc (ALNY), Unitedhealth Group Inc Com (UNH) (-38.4% shares), Canadian Nat Res Ltd Med Term Com (CNQ) (-29.4% shares) and Abbott Laboratories (ABT) (-25.8% shares), compared with its Q1 2026 filing.

How has Capital Research Global Investors's portfolio performed?

A portfolio copying Capital Research Global Investors's 20 largest 13F holdings each quarter, from the day each filing was public, returned +25.5% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +16.3% against +20.1%. Over 5 years: +15.1% a year against +11.6%.

When is Capital Research Global Investors's next 13F filing due?

13F filings are due 45 days after each quarter ends. Capital Research Global Investors's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.